Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the the-events-calendar-category-colors domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6114
KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment – ياهلا
Health

KFSHRC’s New US Patent Opens New Frontiers for Breast Cancer Treatment

King Faisal Specialist Hospital & Research Centre (KFSHRC) announced a significant advancement in stem cell science, securing a U.S. patent for an innovative method that holds promise for breast cancer treatment and regenerative medicine. 

عالم يستخدم كمبيوتر لتحليل صور تحت المجهر

This innovative approach, developed by KFSHRC researchers Abdelilah Aboussekhra, Huda H. Al-Khalaf, and Hazem Ghebeh, involves transforming regular breast cells into multipotent stem cells using specialized culture methods. These stem cells have shown the ability to regenerate mammary tissue in animal models, presenting new possibilities for breast tissue reconstruction and advanced cancer therapies. The foundational research supporting this patent was published in the Molecular and Cellular Biology journal.

This innovation offers a promising foundation for personalized breast cancer treatment, potentially providing enhanced reconstruction options for patients during the post-surgery period. Beyond its impact on regenerative medicine, the technique reflects KFSHRC’s dedication to advancing life-saving therapies that address the needs of cancer patients worldwide.

This patent builds on KFSHRC’s 40-year legacy in stem cell innovation, marked by over 7,649 transplants and more than 500 research publications. As a leader in advanced therapies, including localized CAR T-cell treatment for cancer, KFSHRC continues to set new standards in personalized care and transformative medical research to improve therapeutic outcomes for patients worldwide.

It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world’s best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine. For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa

مقالات ذات صلة

زر الذهاب إلى الأعلى